PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Diabetes & Metabolism Journal10.4093/dmj.2019.00182020442248Glucagon-Like Peptide-1 Receptor Agonist Differentially Affects Brain Activation in Response to Visual Food Cues in Lean and Obese Individuals with Type 2 Diabetes MellitusJae Hyun Bae, Hyung Jin Choi, Kang Ik Kevin Cho, Lee Kyung Kim, Jun Soo Kwon, Young Min Chohttps://e-dmj.org/pdf/10.4093/dmj.2019.0018, https://e-dmj.org/DOIx.php?id=10.4093/dmj.2019.0018, http://e-dmj.org/upload/pdf/dmj-44-248.pdf
Diabetes10.2337/db18-2231-pub201867Supplement_1Combination of Premixed Insulin with Glucagon-Like Peptide-1 Receptor Agonist (GLP-1) for Uncontrolled Type 2 Diabetes Mellitus (T2DM) PatientsSASAN FAZELI, NICOLE EHRHARDThttps://diabetesjournals.org/diabetes/article/67/Supplement_1/2231-PUB/55704/Combination-of-Premixed-Insulin-with-Glucagon-Like, https://diabetesjournals.org/diabetes/article/67/Supplement_1/2231-PUB/55704/Combination-of-Premixed-Insulin-with-Glucagon-Like
Diabetes Therapy10.1007/s13300-020-00894-y20201191965-1982A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes MellitusSanjay Kalra, Rakesh Sahayhttps://link.springer.com/content/pdf/10.1007/s13300-020-00894-y.pdf, https://link.springer.com/article/10.1007/s13300-020-00894-y/fulltext.html, https://link.springer.com/content/pdf/10.1007/s13300-020-00894-y.pdf
The Journal of Korean Diabetes10.4093/jkd.2019.20.3.1492019203149Injectable Therapy for Diabetes Mellitus: Glucagon-Like Peptide-1 Receptor AgonistInkuk Lee, Eun Seok Kanghttps://synapse.koreamed.org/pdf/10.4093/jkd.2019.20.3.149, https://synapse.koreamed.org/DOIx.php?id=10.4093/jkd.2019.20.3.149, http://e-jkd.org/upload/pdf/jkd-20-149.pdf
Clinical Therapeutics10.1016/j.clinthera.2016.07.01320163810e1Experience from Development of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Dulaglutide for Treatment of Type 2 Diabetes MellitusZ. Milicevichttps://api.elsevier.com/content/article/PII:S0149291816304568?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0149291816304568?httpAccept=text/plain
Diabetes10.2337/db18-1108-p201867Supplement_1Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) plus Basal Insulin vs. GLP-1RA in Type 2 Diabetes Mellitus—A Systematic Review and Meta-analysisMUNIZA M. SATTI, TIMOTHY O'BRIEN, AARON LIEWhttps://diabetesjournals.org/diabetes/article/67/Supplement_1/1108-P/54140/Efficacy-and-Safety-of-Glucagon-Like-Peptide-1, https://diabetesjournals.org/diabetes/article/67/Supplement_1/1108-P/54140/Efficacy-and-Safety-of-Glucagon-Like-Peptide-1
Diabetes mellitus10.14341/dm20151s1-1122017203220-230Once-weekly administration of dulaglutide, a glucagon-like peptide-1 receptor agonist, as monotherapy and combination therapy: review of the AWARD studiesMarina V. Shestakova, Ekaterina A. Yudovichhttp://endojournals.ru/index.php/dia/article/viewFile/7078/5005, https://dia-endojournals.ru/dia/article/viewFile/8347/6441, https://dia-endojournals.ru/dia/article/viewFile/8347/6441
Clinical Obesity10.1111/cob.124322021112Efficacy and safety of glucagon‐like peptide‐1/glucagon receptor co‐agonist JNJ ‐64565111 in individuals with obesity without type 2 diabetes mellitus: A randomized dose‐ranging studyMaria Alba, Jaqueline Yee, Mary Ellen Frustaci, Mahesh N. Samtani, Penny Fleckhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/cob.12432, https://onlinelibrary.wiley.com/doi/full-xml/10.1111/cob.12432, https://onlinelibrary.wiley.com/doi/pdf/10.1111/cob.12432
Diabetes mellitus10.14341/dm88042017204286-298Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetesGagik R. Galstyan, Evgeniya A. Karataeva, Ekaterina A. Yudovichhttps://dia-endojournals.ru/dia/article/viewFile/8804/6915, https://dia-endojournals.ru/dia/article/viewFile/8804/6915
Journal of the Endocrine Society10.1210/js.2019-sun-16420193Supplement_1SUN-164 Use of Metformin, Premixed Insulin, and Glucagon-Like Peptide-1 Receptor Agonist as a Therapeutic Approach for Uncontrolled Type 2 Diabetes MellitusSasan Fazeli, Sanjana Rao, Richard Amdur, Nicole Ehrhardthttps://academic.oup.com/jes/article/doi/10.1210/js.2019-SUN-164/5483727